ISPOR 18th Annual European Congress Congress 7-11 November 2015 miCo ... Slovak Medical University ... we would like to thank all who contributed to the ISPOR 18th Annual European Congress,

Download ISPOR 18th Annual European Congress  Congress 7-11 November 2015 miCo ... Slovak Medical University ... we would like to thank all who contributed to the ISPOR 18th Annual European Congress,

Post on 07-Feb-2018

280 views

Category:

Documents

11 download

Embed Size (px)

TRANSCRIPT

  • 1

    ISPOR Congress App: see page 16

    Wifi Network: Ispor

    Password: Milan2015

    www.ispor.org

    PROGRAM ANDSCHEDULE OF EVENTS

    ISPOR 18th Annual European Congress

    7-11 November 2015miCo milaNo CoNgressi

    milaN, italy

    Impacting Health Decision Making with Outcomes Research: Closing the Gap

    Tweet to @ISPORorg using #isPormilan

  • 2

    Membership by Geographic RegionISPOR Membership and ISPOR Regional Chapter Members

    www.ispor.org

    ISPOR Publications in EuropeValue in Health is the official journal of ISPOR. It provides a forum for researchers, health care decision makers, and policy makers to translate pharmacoeconomics and outcomes research into health care decisions.

    > Access these publications at www.ispor.org >> Publications

    8,700+ Regional Chapter Members 3,700+ Regional Chapter Members in Europe!

    Belarus Chapter

    Bosnia-Herzegovina Chapter

    Bulgaria Chapter

    Croatia Chapter

    Cyprus Chapter

    Czech Chapter

    Greece Chapter

    Hungary Chapter

    Italy-Milan Chapter

    Italy-Rome Chapter

    Poland Chapter

    Portugal Chapter

    > If you are interested in joining ISPOR Regional Chapters in Europe, please contact: regionalchapter@ispor.org.> If you are interested in joining the ISPOR Central and Eastern Europe Network, please contact ceenet@ispor.org.

    More than 9,500 Members Worldwide Including 3,600 members in Europe!

    ISPOR Membership

    Regional Chapters and Networks in Europe

    News Across Central & Eastern Europe, the ISPOR Central & Eastern Europe (CEE) Network newsletter, serves as a platform for the exchange of knowledge in the CEE region on current health care systems and policies, outcomes research, and education impacting health care research and policy decision making in CEE.

    Value in Health Regional Issues publishes research and health policy articles specific to the Asia, Latin America, and Central & Eastern Europe, Western Asia and Africa (CEEWA) regions.

    ISPOR Therapeutic and Diagnostic Device Outcomes Research book is available in Bosnian, Polish, Serbian, and Spanish.

    ISPOR Book of Terms is available in multiple European languages.

    2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

    Republic of Macedonia Chapter

    Romania Chapter

    Russia Chapter

    Russia Far East Chapter

    Russia HTA Chapter

    Russia St. Petersburg Chapter

    Serbia Chapter

    Slovakia Chapter

    Slovenia Chapter

    Spain Chapter

    Turkish SCP Chapter

    Ukraine Chapter

  • 3

    505 Lawrence Square Blvd South Lawrenceville, NJ 08648 Toll Free US and Canada: 1-800-992-0643 Tel: +1-609-586-4981 Fax: +1-609-586-4982 Email: info@ispor.org Internet: www.ispor.org

    Translating Outcomes Research to Health Care Decisions

    2015-2016 board of Directors

    PresidentDaniel C. Malone, RPh, PhDProfessor of PharmacyUniversity of ArizonaTucson, AZ USA

    President-electLou Garrison, PhDProfessor, Pharmaceutical Outcomes Research & Policy ProgramUniversity of Washington Seattle, Washington USA

    Past PresidentAdrian Towse, MA, MPhilDirectorOffice of Health Economics London, UK

    DirectorsJosephine Mauskopf, PhDVice President, Health EconomicsRTI Health Solutions Research Triangle Park, NC USA

    Yen-Huei (Tony) Tarn, MS, PhDExecutive DirectorCenter for Pharmaceutical Care DevelopmentTaiwan Pharmacist AssociationTaipei, Taiwan

    Dominik Tomek, PharmD, MPH, PhDInstitute of Clinical & Experimental PharmacologySlovak Medical UniversityBratislava, Slovakia

    Karen Worley, PhDResearch ManagerComprehensive Health Insights (CHI)HumanaCincinnati, OH USA

    Nancy Devlin, PhDDirectorOffice of Health EconomicsLondon, UK

    Manuel Espinoza, MD, MSc, PhDProfessorPublic Health Institute of ChileMinistry of HealthSantiago, Chile

    Dana Goldman, PhDProfessor of PharmacyUniversity of Southern California Los Angeles, CA USA

    TreasurerZeba M. Khan, RPh, PhDVice President, Corporate ResponsibilityCelgene CorporationSummit, NJ USA

    CEO & Executive DirectorNancy S. BergISPORLawrenceville, NJ USA

    Malone

    Daniel C. Malone, RPh, PhD 2015-2016 ISPOR President

    Dear Colleagues,

    As we celebrate ISPORs past accomplishments during our 20th Anniversary year, we are looking to a very bright future with our new strategic plan, updating Vision 2020.

    Beginning with a planning session last winter, the Societys Board of Directors and other leaders have been involved in crafting new Vision and Mission Statements, along with updating the areas of strategic focus. The evolving plan focuses on ISPORs ongoing commitment to strengthen the integrity, advancement, and understanding of health economics and outcomes research globally.

    I am proud to share with you the Mission and Vision Statements approved by the ISPOR Board of Directors. The new ISPOR Mission Statement is:

    To promote health economics and outcomes research excellence to improve decision making for health globally.

    In updating our new Vision and Mission Statement we emphasize the work that we do as researchers, payers, decision and policy makers, academicians, clinicians, and patients.

    The previous Mission Statement, To increase the efficiency, effectiveness, and fairness of health care to improve health, did not focus specifically on health economic and outcomes research. We also wanted to reinforce our position as a global organization.

    Our new Vision Statement:

    ISPOR is the leading global scientific and educational organization for health economics and outcomes research and their use in decision making to improve health.

    The previous Vision Statement, ISPOR is recognized globally as the authority for outcomes research and its use in health care decisions towards improved health, did not include the importance of ISPORs role as a leading educational organization.

    Along with the Vision and Mission, the Board approved 5 Strategic Pillars that support our Vision and Mission.

    SCIENTIFIC AND RESEARCH EXCELLENCE ISPOR is committed to strengthening the integrity, advancement and the understanding and use of health economics and outcomes research among researchers, health technology developers and assessors, regulators, health economists, health care policy makers, payers, providers, patients, populations, and society.

    MEMBER ENGAGEMENT Through its worldwide membership and stakeholder groups, ISPOR has access to the ideas, knowledge, skills, and experiences that enable achievement of its mission. ISPOR offers membership benefits that are valued and essential in members professional growth.

    EDUCATION AND TRAINING Knowledge and skill building are at the core of the ISPOR mission. ISPOR will lead efforts to strengthen and expand capabilities in health economics and outcomes research.

    COMMUNICATION AND COLLABORATION ISPOR will be a valued and reliable resource for translating knowledge into practice for decision makers and stakeholders who include members, providers, payers, patients, professional societies, foundations, health authorities, the media, and others.

    ORGANIZATIONAL VALUES ISPOR embraces a core set of values and standards that underlie all that we do.

    Over the next months, the plan with accompanying goal statements will be shared with the membership.

    A special thank you to CEO and Executive Director Nancy Berg and her staff for driving this planning process, that involved dozens of members in a condensed time frame.

    I personally invite you to join us at the Member Meeting, Updating ISPOR Vision 2020,on Tuesday, November 10 at the 18th Annual European Congress in Milan, Italy where I will present the plan and engage members in discussing the future of our Society.

    International Society for Pharmacoeconomics and Outcomes Research

  • 4

    Letter from the ISPOR President 3

    Table of Contents 4

    Letter from the ISPOR 18th Annual European Congress Program Committee Co-Chairs 5

    Congress Committee Chairs 6

    Congress at-a-Glance 7-8 Tear out entire page for quick reference!

    ISPOR Invitational Group Meetings 9 Tear out entire page for quick reference!

    Congress Room Floor Plan 10 Tear out entire page for quick reference!

    Key Information 11

    Event Sponsors 15

    Congress App Information 16

    Short Course Program 17

    Program & Schedule of Events 25

    Research Poster Presentations Overview 42

    Research Poster Presentations Floor Plan 43

    Issue Panel Descriptions 48

    Workshop Descriptions 55

    ISPOR Forum Descriptions 66

    Sponsored Symposia 69

    ISPOR 18th Annual European Congress Review Committee Members 75

    Invited Speaker & Award Recipient Biographical Information 85

    Exhibit Program 91

    ISPOR Leadership Directory 141

    7-11 November 2015 | MiCo Milano Congressi | Milan, ItalyISPOR 18th Annual European Congress

    TABLE OF CONTENTS

  • 5

    F. Meyer

    Dear Colleagues,

    With great pleasure we would like to welcome you to Milan for the ISPOR 18th Annual European Congress. The theme of the conference, Impacting Health Decision Making with Outcomes Research: Closing the Gap, will be centered on the use of outcomes assessment in decision making: Are we ready to use the developments and scientific endeavor of three decades of outcomes research for strategic policy making and day-to-day health services and technologies financing decisions?

    In the opening plenary session on Monday, Strategy in Motion: The Current and Future Lifecycle Approach to Decision Making on Health Technologies, payers, health technology assessment (HTA) and regulatory leaders, patient and industry representatives, and key decision makers will discuss several issues including the new medical device regulation in Europe, the work underway within the Adaptive Pathways to Patients initiative for drugs, and the European Commissions HTA network plans.

    On Tuesday, in our second plenary session, Outcomes Research: Are We Ready to Put Theory into Practice?, thought-provoking, forward-looking practicing clinicians, HTA body representatives, and public health leaders from both sides of the Atlantic will share their views and discuss the applicability of outcomes assessment in day-to-day practice as well as in strategic decision making.

    In the third plenary session scheduled for Wednesday, Recommendations from the ISPOR Multi-Criteria Decision Analysis Emerging Good Practice Task Force and Remaining Controversies, the ISPOR MCDA Task Force will discuss approaches for conducting MCDA and emerging good practices. This session will be shaped mostly as a panel discussion with experienced, thought-leading, and outspoken panelists discussing areas of controversy and emerging good practice recommendations.

    This Congress is an important forum for acquiring more knowledge and for networking. The scientific novelty is not only guaranteed by activities such as pre-Congress short courses, issue panels, workshops, forums, symposia, podium presentations, and poster presentations, but also by the Social Event. The ISPOR Social Event will take place on Tuesday night: Enjoy a true Milanese experience at the historic Hotel Principe di Savoia in the heart of Milan! Network with colleagues and indulge in the finest classic Italian cuisine!

    Furthermore, we hope that you have time to do some sightseeing in Milan, a wonderful city that gladly welcomes guests from all over the world and provides the opportunity to learn about art, fashion, sport, food, and wine - for which Milan is widely famous!

    Finally, we would like to thank all who contributed to the ISPOR 18th Annual European Congress, especially the Review Committee Co-Chairs and the ISPOR staff. They have all already put great effort into making this Congress a success. ISPOR aims to promote health economics and outcomes research excellence to improve decision making for health globally: we can all contribute to this.

    We hope that you enjoy the ISPOR 18th Annual European Congress and your stay in Milan.

    We look forward to seeing you in Milan!

    Sincerely,

    505 Lawrence Square Blvd South Lawrenceville, NJ 08648 Toll Free US and Canada: 1-800-992-0643 Tel: +1-609-586-4981 Fax: +1-609-586-4982 Email: info@ispor.org Internet: www.ispor.org

    Translating Outcomes Research to Health Care Decisions

    International Society for Pharmacoeconomics and Outcomes Research

    2015-2016 board of Directors

    PresidentDaniel C. Malone, RPh, PhDProfessor of PharmacyUniversity of ArizonaTucson, AZ USA

    President-electLou Garrison, PhDProfessor, Pharmaceutical Outcomes Research & Policy ProgramUniversity of Washington Seattle, Washington USA

    Past PresidentAdrian Towse, MA, MPhilDirectorOffice of Health Economics London, UK

    DirectorsJosephine Mauskopf, PhDVice President, Health EconomicsRTI Health Solutions Research Triangle Park, NC USA

    Yen-Huei (Tony) Tarn, MS, PhDExecutive DirectorCenter for Pharmaceutical Care DevelopmentTaiwan Pharmacist AssociationTaipei, Taiwan

    Dominik Tomek, PharmD, MPH, PhDInstitute of Clinical & Experimental PharmacologySlovak Medical UniversityBratislava, Slovakia

    Karen Worley, PhDResearch ManagerComprehensive Health Insights (CHI)HumanaCincinnati, OH USA

    Nancy Devlin, PhDDirectorOffice of Health EconomicsLondon, UK

    Manuel Espinoza, MD, MSc, PhDProfessorPublic Health Institute of ChileMinistry of HealthSantiago, Chile

    Dana Goldman, PhDProfessor of PharmacyUniversity of Southern California Los Angeles, CA USA

    TreasurerZeba M. Khan, RPh, PhDVice President, Corporate ResponsibilityCelgene CorporationSummit, NJ USA

    CEO & Executive DirectorNancy S. BergISPORLawrenceville, NJ USA

    Meyer

    Lorenzo G. Mantovani, DSc 18th Annual European Congress Co-Chair

    Mantovani

    Franois Meyer, MD 18th Annual European Congress Co-Chair

  • 6

    PROGRAM COMMITTEE CO-CHAIRS:

    Lorenzo G. Mantovani, DSc Associate Professor of Public Health, Research Center on Public Health (CESP), University of Milano-Bicocca, Monza, Italy

    Franois Meyer, MD Advisor to the President, International Affairs, French National Authority for Health (HAS), Saint-Denis La Plaine, France

    RESEARCH REVIEW COMMITTEE CO-CHAIRS:

    Evelyn Walter, PhD Managing Director, Institute for Pharmacoeconomic Research, Vienna, Austria

    Kostas Athanasakis, PhD Research Fellow, National School of Public Health and President of the Hellenic Association of Pharmacoeconomics, Athens, Greece

    Paolo Angelo Cortesi, PhDResearcher, Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy

    Anthony J Hatswell, MScPrincipal Consultant (HTA Methodology), BresMed and Department of Statistical Science, University College London, Sheffield, UK

    ISSUE PANEL REVIEW COMMITTEE CO-CHAIRS:

    Mirn Ryan PhD, DrPH Director of Health Technology Assessment & Deputy Chief Executive Officer, Health Information and Quality Authority, Dublin, Ireland

    Simona de Portu, MSc Reimbursement Manager, Diabetes, EMEA, Medtronic International Trading Srl, Tolochenaz, Switzerland

    Oriol Sol Morales, MD, PhD, MSc Partner, Health Innovation Technology Transfer (HiTT) and Assistant Professor, Health Economics, International University of Catalonia (UIC), Barcelona, Spain

    WORKSHOP REVIEW COMMITTEE CO-CHAIRS:

    Maarten J Postma, PhD Professor, Department of Pharmacy, University of Groningen, Groningen, The Netherlands

    Bertalan Nmeth, MSc Senior Health Economist, Syreon Research Institute,...

Recommended

View more >